Vizzhy Inc. Texas-based, a company focused on healthcare innovation leveraging multi-omics, is in the process of building what it says is the first and largest Generative AI platform based on multi- omics in whole health to help the common man. , medical professionals and researchers.
Vizzhy a team of 40 data scientists, medical professionals and researchers and deep technology experts based in Bengaluru will work on this project. To run the project, the company imported the NVIDIA DGX H100, which claims to be the AI powerhouse and the foundation of the NVIDIA DGX SuperPOD, which helps businesses solve the biggest AI challenges through high performance. this.
Multi-omics (multiple omics) offers possibilities for holistic discovery at multiple levels of biology. By combining multi-omics data, researchers can gain a deeper, holistic understanding of the molecular changes occurring in the human body, and thus doctors can treat all kinds of diseases more effectively. effective with less, but precise medicine. Multi-omics involves a comprehensive analysis of biological data, combining genomics, proteomics, transcriptomics, and metabolomics to unravel intricate disease mechanisms and advance personalized medicine.
Dr. Vishnu Vardhan Pogunulu Srinivasalu, founder of Vizzhy Inc., is an orthopedics doctor hailing from Ballari district in Karnataka. He has an MS, and an MBA in Business Administration and Science & Technology from the Massachusetts Institute of Technology (MIT).
He told The Hindu“What patients need, especially those with multiple diseases, is a holistic approach to understand their body and more effectively treat their complaints instead of treating patients with different drugs prescribed by different doctors. specialist or super-specialist for various diseases caused by metabolic issues. ”
Citing a 2019 National Health and Nutrition Examination Survey (NHANES) in the US, Dr. Srinivasalu said about 88% of adults are metabolically unfit and the average adult has gained 15 kg since the 1970s. A surge in metabolic diseases has pushed America’s annual health care spending to more than $4 trillion, surpassing India’s GDP. Metabolic trends in India are also similar, or unsatisfactory.
“This shocking revelation prompts us to realize that the entire landscape of health care needs to change. The change from the medicine model of specialists to a holistic one method of medicine, a more natural way to treat diseases effectively,” he added.
Vizzhy’s Generative AI platform is able to generate a large amount of new medical data, for the public and patients, medical fraternity and researchers, further expanding the possibilities of research and treatment for metabolic diseases.
“These technologies are evolving in global collaboration, combining original research, expertise, data, and computational capabilities. Our effort is set to explore new ways to manage diseases in the style of life, and it’s about adapting AI to address the underlying cause of metabolic diseases,” said Dr. Srinivasalu.
Vizzhy’s approach is focused on a systems biology paradigm, which emphasizes preventive, predictive, accurate, participatory (the patient has 70% responsibility for managing his health, he argues), and personalized care. health. The synergy of multi-omics and Generative AI is the key to solving the fundamental causes of metabolic diseases.
“Vizzhy Inc. is driving a revolution in healthcare by channeling the powerful combination of multi-omics and Generative AI. The platform will answer all health-related questions from anyone, and generate real, well-researched medical data accordingly,: he explained.
Invested ₹100 crore in research on metabolic diseases
To continue its commitment to fight metabolic diseases through a holistic approach, Vizzhy Inc has decided to invest over ₹100 crore ($12.5 million) in the Sreenivasulu AI for Wellness Center, at the University’s Grainger College of Engineering of Illinois Urbana-Champaign.
This center, led by Prof. Narendra Ahuja, global computer vision scientist, known for establishing India’s first IIIT in Hyderabad, will assemble a team of scientists, engineers, and health system experts committed to solving one of the most urgent challenges to humanity — metabolic diseases. .